| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| GB8214461AGB2098867B (en) | 1981-05-21 | 1982-05-18 | Sustained release pharmaceutical composition | 
| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| GB8115678 | 1981-05-21 | ||
| GB8214461AGB2098867B (en) | 1981-05-21 | 1982-05-18 | Sustained release pharmaceutical composition | 
| Publication Number | Publication Date | 
|---|---|
| GB2098867A GB2098867A (en) | 1982-12-01 | 
| GB2098867Btrue GB2098867B (en) | 1984-10-24 | 
| Application Number | Title | Priority Date | Filing Date | 
|---|---|---|---|
| GB8214461AExpiredGB2098867B (en) | 1981-05-21 | 1982-05-18 | Sustained release pharmaceutical composition | 
| Country | Link | 
|---|---|
| GB (1) | GB2098867B (en) | 
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| US4540566A (en)* | 1984-04-02 | 1985-09-10 | Forest Laboratories, Inc. | Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose | 
| GB2176999B (en)* | 1985-06-22 | 1989-07-12 | Stanley Stewart Davis | Sustained release medicament | 
| SE450087B (en)* | 1985-10-11 | 1987-06-09 | Haessle Ab | GRAINS WITH CONTROLLED RELEASE OF PHARMACIFICALLY ACTIVE SUBSTANCES APPLIED SIGNED ON A COMPACT INSULABLE NUCLEAR MATERIAL | 
| SE455836B (en)* | 1985-10-11 | 1988-08-15 | Haessle Ab | PREPARATION WITH CONTROLLED RELEASE CONTAINING A SALT OF METOPROLOL AND METHOD FOR PREPARING THIS PREPARATION | 
| FR2620332A1 (en)* | 1987-09-11 | 1989-03-17 | Squibb & Sons Inc | PHARMACEUTICAL COMPOSITION HAVING A HIGH MEDICINAL CONTENT, AND PROCESS FOR PREPARING THE SAME | 
| US5049394A (en)* | 1987-09-11 | 1991-09-17 | E. R. Squibb & Sons, Inc. | Pharmaceutical composition containing high drug load and method for preparing same | 
| SE8703881D0 (en)* | 1987-10-08 | 1987-10-08 | Haessle Ab | NEW PHARMACEUTICAL PREPARATION | 
| US4971805A (en)* | 1987-12-23 | 1990-11-20 | Teysan Pharmaceuticals Co., Ltd. | Slow-releasing granules and long acting mixed granules comprising the same | 
| US4938968A (en)* | 1988-07-26 | 1990-07-03 | Norjec Development Associates, Inc. | Controlled release indomethacin | 
| US5133974A (en)* | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations | 
| US5122384A (en)* | 1989-05-05 | 1992-06-16 | Kv Pharmaceutical Company | Oral once-per-day organic nitrate formulation which does not induce tolerance | 
| CA2936746C (en) | 2014-10-31 | 2017-06-27 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder | 
| US10722473B2 (en) | 2018-11-19 | 2020-07-28 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder | 
| Publication number | Publication date | 
|---|---|
| GB2098867A (en) | 1982-12-01 | 
| Publication | Publication Date | Title | 
|---|---|---|
| GB2108841B (en) | Sustained release layered pharmaceutical compositions | |
| GB2053681B (en) | Sustained release pharmaceutical composition | |
| IL58279A0 (en) | Sustained release pharmaceutical compositions | |
| PH25637A (en) | Dipyridamole-containing pharmaceutical form | |
| GB2053682B (en) | Sustained release pharmaceutical compositions | |
| AR243378A1 (en) | Sustained release pharmaceutical composition | |
| AU557693B2 (en) | Pharmaceutical sustained release compounds | |
| ZA824622B (en) | Pharmaceutical compositions | |
| ZA834074B (en) | Pharmaceutical composition | |
| NZ201520A (en) | Substituted aminopyridazines and pharmaceutical compositions | |
| EP0093551A3 (en) | Pharmaceutical composition | |
| ZA825397B (en) | Pharmaceutical compositions | |
| SG21388G (en) | Pharmaceutical formulations | |
| JPS56103110A (en) | Sustained release medicinal composition | |
| GB2098867B (en) | Sustained release pharmaceutical composition | |
| ZA822856B (en) | Pharmaceutical compositions | |
| JPS57149230A (en) | Medicinal composition | |
| JPS57149222A (en) | Granular medicinal composition | |
| GB8329700D0 (en) | Anti-haemophilic pharmaceutical composition | |
| GB8328896D0 (en) | Pharmaceutical composition | |
| DE3278126D1 (en) | Sustained release compositions | |
| MY8700560A (en) | Pharmaceutical compositions | |
| ZA826479B (en) | Pharmaceutical compositions | |
| JPS57181007A (en) | Local drug composition | |
| GB8332653D0 (en) | Pharmaceutical composition | 
| Date | Code | Title | Description | 
|---|---|---|---|
| PE20 | Patent expired after termination of 20 years | Effective date:20020517 |